LSE TECHNOLOGY APPROACH TO GENERATE INNOVATIVE KINASE INHIBITOR DRUGS

Project Information

LSE

Grant agreement ID: 305272

Closed project

Start date 1 February 2013

End date 31 July 2015

Funded under

• Specific Programme "Cooperation": Health

Total cost € 1 883 305,12

EU contribution € 1 449 681,00

Coordinated by

CREABILIS THERAPEUTICS SRL
Italy